Summary of the latest safety advice for medicines and medical device users
Similar Posts
Precautionary recall of blood pressure medication after packaging error
The MHRA has advised pharmacy and healthcare professionals to return all remaining stock to their suppliers
Guidance: Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
Field Safety Notices: 7 to 11 July 2025
List of Field Safety Notices from 7 to 11 July 2025.
Isotretinoin: an expert review of suspected psychiatric and sexual side effects
The review of the safety of isotretinoin has concluded.
MHRA and Department for Education embed medicine safety into school curriculum to empower young people
The importance of medicine safety and how to report side effects of medicines via the Yellow Card scheme is now part of the statutory guidance for schools in England.
Decentralised manufacture: Clinical Trial Authorisation (CTA) and Good Clinical Practice (GCP)
Guidance for clinical trials that use Decentralised Manufactured Investigational Medicinal Products (IMPs).